Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke Tablets for severe pneumonia
ChiCTR2300067998Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Lianhua Qingke in pneumonia (3 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Change and rate of change in APACHE II score. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
Lianhua Qingke
03
Conditions
pneumonia
Beyond the preview
Go deeper on ChiCTR2300067998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067998.